Omnicell Inc. Stock
Omnicell Inc. Stock
Heavy losses for Omnicell Inc. today as the stock fell by -€1.400 (-3.700%).
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Omnicell Inc..
With a target price of 40 € there is a slightly positive potential of 9.89% for Omnicell Inc. compared to the current price of 36.4 €.
Pros and Cons of Omnicell Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omnicell Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omnicell Inc. | -3.700% | 5.202% | 14.465% | -16.514% | -12.500% | -19.469% | -61.684% |
| Integer Hldg | - | 2.521% | 1.667% | -53.788% | -51.969% | -9.630% | -3.937% |
| Healthequity Inc. | 1.860% | 2.500% | -4.094% | -9.392% | -9.890% | 37.815% | 53.271% |
| Bruker Corp. | -2.030% | -6.790% | 4.855% | -31.234% | -30.689% | - | - |
Comments
Omnicell (NASDAQ:OMCL) had its price target raised by analysts at Benchmark Co. from $45.00 to $50.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell (NASDAQ:OMCL) had its price target raised by analysts at Benchmark Co. from $40.00 to $45.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) had its price target lowered by analysts at Piper Sandler from $57.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
News
Why Omnicell Stock Crushed the Market Today
Healthcare tech company Omnicell (NASDAQ: OMCL) was quite the picture of health on Thursday, at least as far as its equity was concerned. An encouraging quarterly earnings report sent its shares
